(19)
(11) EP 3 099 333 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.12.2020 Bulletin 2020/53

(45) Mention of the grant of the patent:
18.11.2020 Bulletin 2020/47

(21) Application number: 15743948.0

(22) Date of filing: 30.01.2015
(51) International Patent Classification (IPC): 
C12Q 1/6883(2018.01)
(86) International application number:
PCT/US2015/013926
(87) International publication number:
WO 2015/117010 (06.08.2015 Gazette 2015/31)

(54)

BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE

BAG3 ALS TARGET ZUR BEHANDLUNG VON HERZINSUFFIZIENZ

BAG3 EN TANT QUE CIBLE POUR LA THÉRAPIE DE L'INSUFFISANCE CARDIAQUE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.01.2014 US 201461934483 P

(43) Date of publication of application:
07.12.2016 Bulletin 2016/49

(60) Divisional application:
20208165.9

(73) Proprietor: Temple University of the Commonwealth System of Higher Education
Philadelphia, PA 19122 (US)

(72) Inventors:
  • FELDMAN, Arthur, M.
    Wynnewood, PA 19096 (US)
  • TILLEY, Douglas, G.
    Bryn Mawr, PA 19010 (US)
  • ZHU, Weizhong
    Cockeysville, MD 21030 (US)
  • KHALILI, Kamel
    Bala Cynwyd, PA 19004 (US)
  • KOCH, Walter, J.
    Broomall, PA 19008 (US)

(74) Representative: Patentanwälte Ruff, Wilhelm, Beier, Dauster & Partner mbB 
Kronenstraße 30
70174 Stuttgart
70174 Stuttgart (DE)


(56) References cited: : 
EP-A1- 1 323 733
WO-A2-2010/138263
EP-A1- 1 323 733
   
  • DUYGU SELCEN ET AL: "Mutation in BAG3 Causes Severe Dominant Childhood Muscular Dystrophy", ANNALS OF NEUROLOGY, JOHN WILEY AND SONS, BOSTON, US, vol. 65, no. 1, 1 January 2009 (2009-01-01), pages 83-89, XP002661988, ISSN: 0364-5134, DOI: 10.1002/ANA.21553
  • BEGAY, R ET AL.: 'ABSTRACT 15073:EXOME SEQUENCING IDENTIFIES BAG3 GENE MUTATION IN DILATED CARDIOMYOPATHY'.' CIRCULATION vol. 128, no. 22 SUP, 2013, XP055357490
  • ODGEREL, Z. ET AL.: 'Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation'.' NEUROMUSCULAR DISORDERS vol. 20, no. 7, 2010, ISSN 0960-8966 pages 438 - 442, XP027104039
  • HOMMA, S. ET AL.: 'BAG3 deficiency results in fulminant myopathy and early lethality'.' THE AMERICAN JOURNAL OF PATHOLOGY vol. 169, no. 3, September 2006, pages 761 - 773, XP055329887
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).